
Results
2
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
CLN
zł19.78
7D
-0.4%
1Y
-17.8%
Genomed Spólka Akcyjna
Market Cap: zł33.6m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł29.00
7D
12.4%
1Y
16.9%